Skip to content
Open access

Clinical outcomes and disparities in advanced therapy use among elderly patients with pulmonary embolism complicated with cardiogenic shock: a nationwide analysis

Oct 2026 · European Heart Journal · 0 citations

Abstract

Pulmonary embolism (PE) complicated by cardiogenic shock (CS) is associated with significant morbidity and mortality. As the population ages, understanding age-related differences in outcomes and management is critical to optimizing care in this high-risk cohort. Using the National Inpatient Sample database, adults hospitalized with PE and CS, stratifying them into elderly (≥80 years) and younger (18–79 years) groups in the U.S. between 2016-2022. Multivariable logistic regression was performed to evaluate age-based differences in in-hospital outcomes and utilization of advanced therapies. Among 55,420 patients with PE and CS, 7,780 (14%) were elderly. In-hospital mortality was significantly higher in elderly patients compared with younger patients (47% vs 37%; adjusted odds ratio [aOR] 1.51, 95% CI 1.43–1.60; p<0.0001). Despite higher mortality, elderly patients were less likely to receive advanced interventions, including mechanical ventilation (30% vs 43%; aOR 0.68, 95% CI 0.64–0.72), extracorporeal membrane oxygenation ECMO (0.2% vs 6%; aOR 0.06, 95% CI 0.04–0.09), Impella support (1% vs 3%; aOR 0.44, 95% CI 0.35–0.56), and intra-aortic balloon pump IABP (3% vs 5%; aOR 0.54, 95% CI 0.46–0.63) (all p<0.0001). Elderly patients also had higher odds of heart block (15% vs. 10%; aOR 1.49; 95% CI: 1.37 - 1.61), permanent pacemaker implantation (2% vs. 1%; aOR 2.28; 95% CI: 1.80 - 2.90) and in-hospital myocardial infarction (29% vs. 23%; aOR 1.32; 95% CI: 1.25 - 1.41); all p<0.0001. Elderly patients with PE complicated by CS experience significantly higher in-hospital mortality while receiving fewer advanced mechanical and circulatory support therapies. These findings suggest potential management disparities and underscore the importance of individualized, age-conscious decision-making that balances clinical risk, frailty, and patient preferences to improve outcomes in this vulnerable population.Central IllustrationBar Graph

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.